Jamal Hasoon, MD
Anesthesiology · Houston, TXNPI 1821484031
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by SPR Therapeutics, Inc at 44.5% of the total. Reporting peaked in 2022 at $19,383 and has fallen 65.6% since, to $6,668 in 2025. Among anesthesiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $157.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$25K
- Nevro Corp.$13K
- Boston Scientific$4K
- Biotronik NRO, Inc.$3K
- Abbott$2K
- Medtronic$2K
- plus $7K from 26 others
What the payments were for
- Consulting fees$26,22047%
- Speaking & faculty fees$6,80512%
- Travel & lodging$3,2786%
- Food & beverage$16,97530%
- Education$2,4534%
- Entertainment$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 62 | $24,801 |
| Nevro Corp. | 44 | $13,384 |
| Boston Scientific | 77 | $3,713 |
| Biotronik NRO, Inc. | 10 | $3,028 |
| Abbott | 22 | $2,144 |
| Medtronic(2 entities) | 24 | $1,836 |
| Spinal Simplicity, LLC | 3 | $1,645 |
| Relievant Medsystems, Inc. | 8 | $1,014 |
| Painteq LLC | 5 | $975 |
| Nalu Medical, Inc. | 19 | $789 |
| Si-bone, Inc. | 5 | $441 |
| Saluda Medical Americas, Inc. | 12 | $343 |
| MML US, Inc. | 2 | $270 |
| Averitas Pharma Inc. | 2 | $167 |
| AbbVie(2 entities) | 7 | $125 |
| GRT US Holding, Inc. | 5 | $97 |
| Bioventus LLC | 2 | $93 |
| Flowonix Medical Incorporated | 1 | $93 |
| Arbor Pharmaceuticals, Inc. | 6 | $91 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $71 |
| Redhill Biopharma Inc. | 4 | $70 |
| Amgen(2 entities) | 3 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $63 |
| Biodelivery Sciences International, Inc. | 5 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Novartis | 3 | $58 |
| Forte Bio-pharma LLC | 1 | $52 |
| Vertex | 1 | $42 |
| IBSA Pharma Inc. | 2 | $32 |
| Foundation Fusion Solutions, LLC | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$23,246
- Senza$10,891
- Prospera$2,848
- HA MINUTEMAN G3-R$1,643
- Intracept$1,640
- PROCLAIM$1,105
- SPECTRA WAVEWRITER$1,030
- Omnia$940
- PAINTEQ$878
- INTELLIS$706
- Senza Spinal Cord Stimulation System$620
- Nalu Neurostimulation System$496
- Proclaim IPG$484
- INTELLIS ADAPTIVESTIM$425
- GENERAL PAIN MANAGEMENT$344
- ReActiv8$270
- Assurity Pacemaker$178
- GALLANT$123
- Qutenza$122
- RESTORE$119
How this compares
$55,756 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 12 | $26,164 |
| UbrelvyUbrogepant | 14 | $17,934 |
| BelbucaBuprenorphine Hcl | 14 | $10,261 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 287 | $6,906 |
| Celecoxib | 141 | $2,997 |
| Pregabalin | 188 | $2,981 |
| Gabapentin | 215 | $2,056 |
| Morphine Sulfate ErMorphine Sulfate | 73 | $1,892 |
| Etodolac | 50 | $1,873 |
| Tizanidine Hcl | 205 | $1,871 |
| Naloxone Hcl | 24 | $1,345 |
| Diclofenac Sodium | 39 | $1,194 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 95 | $1,171 |
| Methocarbamol | 59 | $748 |
| Cyclobenzaprine Hcl | 78 | $592 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $125 | $17,93414 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $88 | $10,26114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,899 anesthesiology providers in Texas.
Other anesthesiology in Houston
- Tong GanHouston$700K
- Gabriel MenaHouston$494K
- Harold MinkowitzHouston$224K
- Eric ChanHouston$128K
- John ZakiHouston$109K
- Barbara OrlandoHouston$42K
- Byron BakerHouston$41K
- Javier LasalaHouston$17K
- Airat AgbetobaHouston$16K
- Karla SamaniegoHouston$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.